Status:
COMPLETED
Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation
Lead Sponsor:
Dr. Ashish Kumar
Conditions:
Cirrhosis
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
Background and Objectives: Patients with liver cirrhosis are more prone to develop reduced bone mineral density i.e. hepatic osteodystrophy (HOD). It includes both osteopenia and osteoporosis and may ...
Eligibility Criteria
Inclusion
- Liver Cirrhosis
- Age 18-70 years
- Informed and written consent
Exclusion
- Chronic renal failure
- Prolonged steroid use more than 3 months
- Patients on immunosuppressive therapy
- Primary hyperparathyroidism
- Post menopausal women
- Pregnancy
- Cushing's syndrome
- Malignancy
- HIV Co-infection
Key Trial Info
Start Date :
August 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT02249741
Start Date
August 1 2012
End Date
February 1 2014
Last Update
September 26 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gastroenterology & Hepatology, Sir Ganga Ram Hospital
New Delhi, New Delhi, India, 110060